Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to its new drug application for zongertinib (BI 1810631) for the treatment of adult ...

Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...

The primary primary cancer – which had already spread throughout her skeleton and also to her brain – was later revealed to ...

Lung cancer cases are rising among non-smokers. Learn about the causes, symptoms, and prevention strategies from a medical expert. Protect yourself and your loved ones with this vital information.

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

Personalised mRNA vaccines have shown positive results as pancreatic cancer treatment, a phase 1 clinical trial found.

EXCLUSIVE: Retired David Mather was dealt a shocking blow when told his tiredness was stage-IV lung cancer - now a new UK ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

Healthcare innovator's latest acquisition to enhance lung health program for employers and patients PALO ALTO, CA, UNITED STATES, Febr ...

fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur. ... Tumor DNA in the Blood Can ...